Products > Catalog Proteins > Immune Checkpoint

Recombinant Human CD27/TNFRSF7 Protein (RP00326)



Product nameRecombinant Human CD27/TNFRSF7 Protein
Catalog No.RP00326
DescriptionRecombinant Human CD27/TNFRSF7 Protein is produced by Human Cell expression system. The target protein is expressed with sequence (Thr21-Ile192) of human CD27/TNFRSF7 (Accession #P26842) fused with an Fc, 6×His tag at the C-terminus.
Bio-ActivityMeasured by its ability to inhibit the proliferation of mouse T cells induced by CD27 Ligand and anti-CD3. The ED50 for this effect is 0.75-3 μg/mL in the presence of 10 μg/mL (100 μL/well) Recombinant Human CD27/TNFRSF7 and anti-CD3.
Purity> 95% by SDS-PAGE.
Endotoxin< 1 EU/μg of the protein by LAL method.
FormulationLyophilized from a 0.2 μm filtered solution of 20 mM Tris, 150 mM NaCl, pH 8.0.
This protein is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor.
SynonymS152; S152.LPFS2; T14; TNFRSF7; Tp55
Expressed HostHuman cells
TagFc, 6×His tag at the C-terminus
Swiss portP26842
Gene ID939
StorageStore the lyophilized protein at -20°C to -80 °C for long term.|After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.
ReconstitutionReconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.

Inquire About This Product

Submit your question about RP00326 below and we will get back to you within one business day.

Alternatively, call us at 888.754.5670.

Select size and quantity
Contact us to order